Free Trial

Genus (LON:GNS) Sets New 12-Month High - Here's What Happened

Genus logo with Medical background

Key Points

  • Genus plc's shares reached a new 52-week high of GBX 2,665 ($35.96) with a trading volume of 198,722 shares.
  • Analysts have a consensus "Buy" rating for Genus, with one target price at GBX 2,750, significantly higher than the current trading price.
  • The company has a market cap of £1.73 billion and operates in animal genetics across various global regions.
  • Five stocks to consider instead of Genus.

Shares of Genus plc (LON:GNS - Get Free Report) hit a new 52-week high on Wednesday . The stock traded as high as GBX 2,665 ($36.02) and last traded at GBX 2,655 ($35.89), with a volume of 198722 shares changing hands. The stock had previously closed at GBX 2,610 ($35.28).

Analysts Set New Price Targets

Several equities research analysts have weighed in on the company. Shore Capital increased their price objective on Genus from GBX 2,630 to GBX 2,900 and gave the stock a "buy" rating in a report on Thursday. Deutsche Bank Aktiengesellschaft increased their price objective on Genus from GBX 2,250 to GBX 2,550 and gave the stock a "buy" rating in a report on Tuesday, July 15th. Two analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Genus currently has a consensus rating of "Buy" and an average price target of GBX 2,725.

Get Our Latest Report on Genus

Genus Trading Down 0.9%

The company has a debt-to-equity ratio of 53.12, a quick ratio of 1.08 and a current ratio of 1.80. The company has a market cap of £1.76 billion, a P/E ratio of 222.98, a price-to-earnings-growth ratio of 2.87 and a beta of 0.37. The stock has a 50-day moving average of GBX 2,317.70 and a two-hundred day moving average of GBX 2,029.96.

About Genus

(Get Free Report)

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.

Featured Articles

Should You Invest $1,000 in Genus Right Now?

Before you consider Genus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genus wasn't on the list.

While Genus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.